Fine Organic Industries Ltd. (FINEORG) — Tipsheet

Fine Organic hits a capacity ceiling, revenue growth stalled until FY28

Tipsheet Editorial — Tue, 26 May 2026 18:58:27 GMT

Management expects flat revenue for the next three years as manufacturing plants run at full capacity. EBITDA margin guidance is also cut to 18-20%.

What’s new

Revenue will remain flat until H2 FY28 due to full capacity utilization.
Sustainable EBITDA margin guidance lowered to 18-20% from 20-22%.
New SEZ plant near JNPA is not expected to start production until H2 FY28.

Why it matters

The company is effectively in a growth holding pattern for the next three years. While the expansion into the US and the acquisition of Malaysia-based Oleofine Organics provide a long-term roadmap, the immediate reality is a margin squeeze from high raw material costs and a hard cap on output.

What we’re watching

Progress on the US manufacturing facility in South Carolina.
Integration of the 80% stake in Oleofine Organics.
Any volatility in vegetable oil prices impacting the 18-20% margin target.

The full read

Fine Organic Industries is entering a period of stagnant growth. Chairman Mukesh Shah told analysts that revenue will remain flat through the first half of FY28 because the company's current manufacturing facilities are running at full capacity. The wait for relief is long, as the new SEZ plant near JNPA is not expected to start commercial production until the second half of FY28. Compounding the volume constraints, the company lowered its sustainable EBITDA margin guidance to 18-20%, down from the previous 20-22% range, citing persistent global vegetable oil supply tightness. The company is attempting to build future capacity through an ₹82.9 crore acquisition of an 80% stake in Malaysian firm Oleofine Organics and land acquisition for a new US subsidiary in South Carolina. For now, however, the company is constrained by its own success in filling its existing plants.

Primary source: BSE · NSE

Fine Organic cuts margin guidance, flags flat revenue till FY28

Tipsheet Editorial — Thu, 21 May 2026 16:53:01 GMT

Capacity constraints until SEZ plant in H2 FY28, raw material pressures, and shift to short-term contracts push sustainable EBITDA margin down to 18-20%.

What’s new

Revenue growth will be flat through FY28 due to capacity constraints until the SEZ plant is commissioned in H2 FY28.
Management slashed sustainable EBITDA margin guidance to 18-20% from the earlier 20-22%.
Raw material costs are under pressure from palm oil scarcity and freight disruption; company has shifted to short-term contracts.

Why it matters

Fine Organic is telling investors that the next two years will see no topline growth and structurally lower margins. The margin downgrade is especially significant — it's a rare mid-cycle revision by a management that has historically been conservative. The shift to short-term contracts suggests pricing power is eroding, at least temporarily.

What we’re watching

When the SEZ plant gets operational — any delays push the growth recovery further out.
Whether palm oil and freight costs ease, which could help margins recover ahead of schedule.
If the company revisits its capital allocation given the flat growth outlook.

The full read

Fine Organic Industries' FY26 concall delivered a rare dose of realism. Revenue will be flat through FY28 because the SEZ plant — the next growth lever — won't be ready until the second half of that year. Meanwhile, palm oil scarcity and freight disruption are squeezing raw material costs, forcing the company into short-term contracts that limit pricing power. Management didn't sugarcoat it: sustainable EBITDA margins are now 18-20%, down from the 20-22% it previously held out. That two-point cut may not sound dramatic, but for a company whose valuation has been built on consistent margin expansion, it's a material reset. The open question is whether the SEZ plant delivers the step-change in revenue and margin that the current stock price still discounts.

Primary source: BSE · NSE

Fine Organic's Q4 PAT jumps 21%, but story already priced in

Tipsheet Editorial — Wed, 20 May 2026 20:25:00 GMT

Revenue up 3.1% to ₹625 cr, PAT at ₹117.5 cr. Full-year PAT flat at ₹417 cr. Strategic updates from two days ago overshadow the print.

What’s new

Q4 revenue grew 3.1% to ₹625.3 cr.
Q4 PAT jumped 21% to ₹117.5 cr.
Full-year PAT flat at ₹417.1 cr.

Why it matters

A clean beat on Q4 profitability, but the strategic story — US subsidiary, Thailand JV, Malaysia acquisition — was already out. This filing confirms numbers, nothing more.

What we’re watching

Organic revenue trajectory given flat FY26 PAT.
Any integration updates on the Malaysia acquisition.
US subsidiary ramp-up in coming quarters.

The full read

Fine Organic reported a solid Q4 with PAT up 21% on revenue of ₹625 crore, but the full-year picture is flat. The company had already front-loaded its strategic moves — US subsidiary, Thailand JV, Malaysia buy — in a board filing two days ago. This quarterly release adds no new information beyond the confirmed numbers. For a stock that trades on its growth story, the FY26 PAT flat-line is the real anchor, not the Q4 beat.

Primary source: BSE · NSE